Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis

The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk stratification of patients with COVID-19, upon hospital admission. Charlson Comorbidity Index (CCI) is a validated, simple, and readily appl...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes & metabolic syndrome clinical research & reviews Vol. 14; no. 6; pp. 2103 - 2109
Main Authors: Tuty Kuswardhani, R.A., Henrina, Joshua, Pranata, Raymond, Anthonius Lim, Michael, Lawrensia, Sherly, Suastika, Ketut
Format: Journal Article
Language:English
Published: Netherlands Elsevier Ltd 01-11-2020
Diabetes India. Published by Elsevier Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk stratification of patients with COVID-19, upon hospital admission. Charlson Comorbidity Index (CCI) is a validated, simple, and readily applicable method of estimating the risk of death from comorbid disease and has been widely used as a predictor of long-term prognosis and survival. We performed a systematic review and meta-analysis of CCI score and a composite of poor outcomes through several databases. Compared to a CCI score of 0, a CCI score of 1–2 and CCI score of ≥3 was prognostically associated with mortality and associated with a composite of poor outcomes. Per point increase of CCI score also increased mortality risk by 16%. Moreover, a higher mean CCI score also significantly associated with mortality and disease severity. CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients. •The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities.•Charlson Comorbidity Index (CCI) has been widely used as a predictor of long-term prognosis and survival.•Higher and per point increase of CCI Score is associated with poor outcomes.•CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients.
AbstractList • The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. • Charlson Comorbidity Index (CCI) has been widely used as a predictor of long-term prognosis and survival. • Higher and per point increase of CCI Score is associated with poor outcomes. • CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients.
The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk stratification of patients with COVID-19, upon hospital admission. Charlson Comorbidity Index (CCI) is a validated, simple, and readily applicable method of estimating the risk of death from comorbid disease and has been widely used as a predictor of long-term prognosis and survival.BACKGROUND AND AIMSThe ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk stratification of patients with COVID-19, upon hospital admission. Charlson Comorbidity Index (CCI) is a validated, simple, and readily applicable method of estimating the risk of death from comorbid disease and has been widely used as a predictor of long-term prognosis and survival.We performed a systematic review and meta-analysis of CCI score and a composite of poor outcomes through several databases.METHODSWe performed a systematic review and meta-analysis of CCI score and a composite of poor outcomes through several databases.Compared to a CCI score of 0, a CCI score of 1-2 and CCI score of ≥3 was prognostically associated with mortality and associated with a composite of poor outcomes. Per point increase of CCI score also increased mortality risk by 16%. Moreover, a higher mean CCI score also significantly associated with mortality and disease severity.RESULTSCompared to a CCI score of 0, a CCI score of 1-2 and CCI score of ≥3 was prognostically associated with mortality and associated with a composite of poor outcomes. Per point increase of CCI score also increased mortality risk by 16%. Moreover, a higher mean CCI score also significantly associated with mortality and disease severity.CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients.CONCLUSIONCCI score should be utilized for risk stratifications of hospitalized COVID-19 patients.
The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk stratification of patients with COVID-19, upon hospital admission. Charlson Comorbidity Index (CCI) is a validated, simple, and readily applicable method of estimating the risk of death from comorbid disease and has been widely used as a predictor of long-term prognosis and survival. We performed a systematic review and meta-analysis of CCI score and a composite of poor outcomes through several databases. Compared to a CCI score of 0, a CCI score of 1–2 and CCI score of ≥3 was prognostically associated with mortality and associated with a composite of poor outcomes. Per point increase of CCI score also increased mortality risk by 16%. Moreover, a higher mean CCI score also significantly associated with mortality and disease severity. CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients. •The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities.•Charlson Comorbidity Index (CCI) has been widely used as a predictor of long-term prognosis and survival.•Higher and per point increase of CCI Score is associated with poor outcomes.•CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients.
The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk stratification of patients with COVID-19, upon hospital admission. Charlson Comorbidity Index (CCI) is a validated, simple, and readily applicable method of estimating the risk of death from comorbid disease and has been widely used as a predictor of long-term prognosis and survival. We performed a systematic review and meta-analysis of CCI score and a composite of poor outcomes through several databases. Compared to a CCI score of 0, a CCI score of 1-2 and CCI score of ≥3 was prognostically associated with mortality and associated with a composite of poor outcomes. Per point increase of CCI score also increased mortality risk by 16%. Moreover, a higher mean CCI score also significantly associated with mortality and disease severity. CCI score should be utilized for risk stratifications of hospitalized COVID-19 patients.
Author Pranata, Raymond
Henrina, Joshua
Lawrensia, Sherly
Anthonius Lim, Michael
Suastika, Ketut
Tuty Kuswardhani, R.A.
Author_xml – sequence: 1
  givenname: R.A.
  surname: Tuty Kuswardhani
  fullname: Tuty Kuswardhani, R.A.
  email: tutykuswardhani@yahoo.com, tutykuswardhani@unud.ac.id
  organization: Department of Internal Medicine, Faculty of Medicine, Udayana University, Sanglah Teaching Hospital, Denpasar- Bali, Indonesia
– sequence: 2
  givenname: Joshua
  surname: Henrina
  fullname: Henrina, Joshua
  email: joshuahenrina@gmail.com
  organization: RSUD Balaraja, Tangerang, Indonesia
– sequence: 3
  givenname: Raymond
  surname: Pranata
  fullname: Pranata, Raymond
  email: raymond_pranata@hotmail.com
  organization: Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia
– sequence: 4
  givenname: Michael
  surname: Anthonius Lim
  fullname: Anthonius Lim, Michael
  email: lim.michael.a@gmail.com
  organization: Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia
– sequence: 5
  givenname: Sherly
  surname: Lawrensia
  fullname: Lawrensia, Sherly
  email: sherlylawrensia@gmail.com
  organization: Ken Saras General Hospital, Semarang, Indonesia
– sequence: 6
  givenname: Ketut
  surname: Suastika
  fullname: Suastika, Ketut
  email: ksuas@unud.ac.id
  organization: Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Udayana University Denpasar, Bali, Indonesia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33161221$$D View this record in MEDLINE/PubMed
BookMark eNp9UctuFDEQtFAQecAHcEE-cpnF9jwNElK0vCJFyiXianntNvFqxh7c3iT79_FkQwQXTnZXV1e3qk7JUYgBCHnL2Yoz3n3YrizerwQTS71iQrwgJ3zoh4rVdXP0-OdVwwQ_JqeIW8baVgr5ihzXNe-4EPyE3K1vdBoxBmriFNPGW5_31AcL91QHS_WCzxF9BhodnWNMNO5yAQELja6vfl58qbiks84eQsaP9JziHjNMBTA0wa2Hu0epCbKudNDjHj2-Ji-dHhHePL1n5Prb1-v1j-ry6vvF-vyyMi3vc9UaJqHbsK5jzImNcb112tpSGdCc9dK5RrimZa0RrnONaWzb1066gQ0N7-oz8vkgO-82E1hTLkx6VHPyk057FbVX_3aCv1G_4q3qWznUPS8C758EUvy9A8xq8mhgHHWAuEMlmnaQnZBs2cUPVJMiYgL3vIYzteSltqrkpZa8FqjkVWbe_X3f88SfgArh04EAxaRiZVJois8GrE9gsrLR_0f-AZ7vqhc
CitedBy_id crossref_primary_10_32322_jhsm_1147178
crossref_primary_10_3390_jpm12091472
crossref_primary_10_2139_ssrn_4095318
crossref_primary_10_1097_MD_0000000000030474
crossref_primary_10_1007_s41999_023_00836_4
crossref_primary_10_12688_f1000research_108972_2
crossref_primary_10_1007_s40801_023_00360_8
crossref_primary_10_12688_f1000research_108972_1
crossref_primary_10_3390_jcm11237064
crossref_primary_10_3390_jcm10163657
crossref_primary_10_1017_dmp_2022_308
crossref_primary_10_3390_jpm11100989
crossref_primary_10_1016_j_jemermed_2024_06_004
crossref_primary_10_1590_0037_8682_0878_2020
crossref_primary_10_1038_s41467_023_38756_3
crossref_primary_10_3389_fmed_2021_670195
crossref_primary_10_1016_j_mhp_2022_200233
crossref_primary_10_3346_jkms_2024_39_e214
crossref_primary_10_4103_jfmpc_jfmpc_57_23
crossref_primary_10_1155_2023_2771149
crossref_primary_10_1080_00365521_2024_2310161
crossref_primary_10_3390_ijerph191912746
crossref_primary_10_1007_s12325_022_02293_0
crossref_primary_10_1002_jmv_29152
crossref_primary_10_1186_s12985_024_02360_8
crossref_primary_10_3390_microorganisms12040725
crossref_primary_10_3390_jcm10143112
crossref_primary_10_1186_s12874_021_01340_8
crossref_primary_10_3389_fpubh_2023_1235745
crossref_primary_10_2478_prilozi_2023_0044
crossref_primary_10_3389_fmed_2021_666949
crossref_primary_10_4081_itjm_2023_1608
crossref_primary_10_1016_j_ajem_2022_03_011
crossref_primary_10_2478_jccm_2022_0010
crossref_primary_10_3390_diagnostics12092069
crossref_primary_10_1007_s40273_023_01326_y
crossref_primary_10_1371_journal_pone_0257775
crossref_primary_10_3390_jcm11071898
crossref_primary_10_3389_fmed_2022_893306
crossref_primary_10_1136_gutjnl_2020_323800
crossref_primary_10_3889_oamjms_2022_10591
crossref_primary_10_1002_ueg2_12165
crossref_primary_10_1038_s41598_021_85813_2
crossref_primary_10_3390_medicina58060769
crossref_primary_10_1093_brain_awac463
crossref_primary_10_3390_ijerph20054049
crossref_primary_10_3889_oamjms_2021_7235
crossref_primary_10_1007_s40615_022_01274_x
crossref_primary_10_5005_jp_journals_10071_23946
crossref_primary_10_3390_math11132842
crossref_primary_10_4103_sjmms_sjmms_138_23
crossref_primary_10_4178_epih_e2024038
crossref_primary_10_1097_MLR_0000000000001654
crossref_primary_10_1186_s12877_022_03274_2
crossref_primary_10_7759_cureus_19690
crossref_primary_10_3390_jcm12196255
crossref_primary_10_1590_fm_2024_37112
crossref_primary_10_1016_j_ijid_2021_06_051
crossref_primary_10_3390_jpm13040628
crossref_primary_10_1080_00325481_2022_2069356
crossref_primary_10_19127_bshealthscience_1109017
crossref_primary_10_1016_j_ijregi_2022_09_007
crossref_primary_10_1016_j_ijid_2021_05_016
crossref_primary_10_1097_CCE_0000000000000662
crossref_primary_10_1136_jech_2021_216778
crossref_primary_10_3899_jrheum_220762
crossref_primary_10_21320_1818_474X_2021_3_47_60
crossref_primary_10_1111_aas_14326
crossref_primary_10_3390_vaccines11010190
crossref_primary_10_36150_2499_6564_N470
crossref_primary_10_1016_j_medcle_2023_03_025
crossref_primary_10_3390_antibiotics11111598
crossref_primary_10_3390_jcm11247413
crossref_primary_10_7759_cureus_28953
crossref_primary_10_1038_s41598_024_60733_z
crossref_primary_10_1136_bmjopen_2021_054869
crossref_primary_10_1016_j_jorep_2024_100419
crossref_primary_10_3390_jcm12031042
crossref_primary_10_7759_cureus_43888
crossref_primary_10_1007_s00423_022_02495_8
crossref_primary_10_31436_ijiok_v1i1_6
crossref_primary_10_3390_ijerph19063597
crossref_primary_10_1002_agm2_12238
crossref_primary_10_3389_fragi_2022_883724
crossref_primary_10_1016_j_intimp_2021_107723
crossref_primary_10_1186_s12890_023_02807_8
crossref_primary_10_1016_j_medcli_2023_03_027
crossref_primary_10_1097_CCE_0000000000000799
crossref_primary_10_35339_ekm_2022_91_1_msh
crossref_primary_10_1016_j_obmed_2021_100333
crossref_primary_10_1111_papr_13321
crossref_primary_10_4103_ijn_ijn_293_21
crossref_primary_10_1016_j_jiph_2024_03_015
crossref_primary_10_11150_kansenshogakuzasshi_96_245
crossref_primary_10_1093_cid_ciad345
crossref_primary_10_1097_MD_0000000000036777
crossref_primary_10_3390_diagnostics12122970
crossref_primary_10_3346_jkms_2023_38_e99
crossref_primary_10_5435_JAAOS_D_23_00784
crossref_primary_10_3389_fneur_2023_1125359
crossref_primary_10_1016_j_msard_2022_103964
crossref_primary_10_1111_imj_15914
crossref_primary_10_1136_bmjopen_2022_063573
crossref_primary_10_1038_s41522_022_00330_y
crossref_primary_10_1093_biomethods_bpac017
crossref_primary_10_1007_s00018_021_03808_8
crossref_primary_10_7759_cureus_17255
crossref_primary_10_7759_cureus_23012
crossref_primary_10_3390_pathogens12101264
crossref_primary_10_1371_journal_pone_0243700
crossref_primary_10_3390_medicina59040657
crossref_primary_10_1016_j_bbih_2022_100425
crossref_primary_10_3390_biomedicines11030831
crossref_primary_10_1007_s11606_021_07152_2
crossref_primary_10_1016_j_ijid_2021_07_049
crossref_primary_10_1038_s41598_022_14643_7
crossref_primary_10_1186_s12889_022_13635_6
crossref_primary_10_1016_j_archger_2020_104324
crossref_primary_10_1016_j_cyto_2023_156434
crossref_primary_10_1097_MD_0000000000032343
crossref_primary_10_31436_integrationknowledge_vol1iss1_6
crossref_primary_10_3390_jpm12122037
crossref_primary_10_1186_s12931_023_02369_7
crossref_primary_10_1016_j_archger_2021_104388
crossref_primary_10_1159_000519385
crossref_primary_10_1186_s12879_024_09466_y
crossref_primary_10_25122_jml_2022_0237
crossref_primary_10_26508_lsa_202201396
crossref_primary_10_1097_MEG_0000000000002091
crossref_primary_10_1186_s44158_022_00038_7
crossref_primary_10_1016_j_pan_2024_02_010
crossref_primary_10_1186_s40249_023_01057_4
crossref_primary_10_1177_10848223241235960
crossref_primary_10_4266_acc_2022_00017
crossref_primary_10_2196_41404
crossref_primary_10_3390_cancers14051173
crossref_primary_10_1016_j_mhp_2022_200247
crossref_primary_10_1186_s12877_022_03681_5
crossref_primary_10_1016_j_anr_2022_05_002
crossref_primary_10_1111_psyg_13113
crossref_primary_10_3389_fmed_2021_695195
crossref_primary_10_3389_fnut_2022_837458
crossref_primary_10_1016_j_clnesp_2021_04_001
crossref_primary_10_1186_s13019_023_02169_6
crossref_primary_10_3390_ijerph19031104
crossref_primary_10_1016_j_cmi_2023_04_028
crossref_primary_10_1177_21514593211040611
crossref_primary_10_3390_antibiotics12071124
crossref_primary_10_1016_j_gastha_2022_08_004
crossref_primary_10_3390_healthcare10020362
crossref_primary_10_3390_life11060561
crossref_primary_10_1016_j_ajem_2022_04_008
crossref_primary_10_1177_2473974X211016283
crossref_primary_10_1016_j_dsx_2021_01_003
crossref_primary_10_7759_cureus_52321
crossref_primary_10_1016_j_pcd_2021_12_008
crossref_primary_10_23736_S2784_8477_22_02007_1
crossref_primary_10_1136_bmjopen_2021_049475
crossref_primary_10_2807_1560_7917_ES_2022_27_35_2100883
crossref_primary_10_3390_biology11060937
crossref_primary_10_1093_ehjqcco_qcad074
crossref_primary_10_1177_2151459321992746
crossref_primary_10_3390_microorganisms10040806
crossref_primary_10_1016_j_dsx_2022_102395
crossref_primary_10_1089_pmr_2022_0041
crossref_primary_10_2147_IJGM_S374246
crossref_primary_10_1007_s15010_021_01699_2
crossref_primary_10_1177_10760296231219252
crossref_primary_10_1111_ped_15084
crossref_primary_10_5005_jp_journals_10071_23973
crossref_primary_10_3390_ijerph19127473
Cites_doi 10.1186/1471-2288-14-135
10.1016/j.dsx.2020.06.022
10.1016/j.jstrokecerebrovasdis.2020.105185
10.1177/1753466620937175
10.1016/j.dsx.2020.08.003
10.1177/1179548420959165
10.1161/HYPERTENSIONAHA.120.15324
10.1016/j.dsx.2020.06.050
10.5588/ijtld.20.0278
10.1056/NEJMsa2011686
10.1183/13993003.00547-2020
10.1016/j.dsx.2020.06.047
10.1016/j.jstrokecerebrovasdis.2020.104949
10.1007/s11739-020-02428-7
10.1093/aje/kwq433
10.1111/joim.13119
10.1007/s10654-010-9491-z
10.1016/j.dsx.2020.03.012
10.1136/heartjnl-2013-304588
10.1038/s41430-020-0652-1
10.1681/ASN.2020040470
10.1097/MLR.0b013e318297429c
10.1177/1753466620942131
10.1016/j.ajem.2020.07.009
10.1016/j.diabet.2020.07.005
10.1016/j.phrs.2020.104931
10.1016/j.dsx.2020.04.018
10.1007/s11606-020-05991-z
10.1016/0021-9681(87)90171-8
10.1177/0962280216669183
ContentType Journal Article
Copyright 2020 Diabetes India
Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.
2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. 2020 Diabetes India
Copyright_xml – notice: 2020 Diabetes India
– notice: Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.
– notice: 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. 2020 Diabetes India
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1016/j.dsx.2020.10.022
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1878-0334
EndPage 2109
ExternalDocumentID 10_1016_j_dsx_2020_10_022
33161221
S1871402120304100
Genre Meta-Analysis
Systematic Review
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXUO
ABBQC
ABMAC
ABMZM
ABXDB
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OB0
ON-
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SDF
SDG
SES
SSH
SSZ
T5K
Z5R
~G-
AAXKI
AFJKZ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c517t-5c09e6b06600f2bcf7dfadd600cea1079ff42f4505c2f6f4c4d573f9f8084163
ISSN 1871-4021
1878-0334
IngestDate Tue Sep 17 21:27:31 EDT 2024
Sat Oct 26 02:02:55 EDT 2024
Thu Sep 26 17:46:36 EDT 2024
Sat Nov 02 12:24:55 EDT 2024
Tue Jul 16 04:30:40 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords COVID-19
Severity
Mechanical ventilation
Mortality
Charlson comorbidity index
Language English
License Copyright © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c517t-5c09e6b06600f2bcf7dfadd600cea1079ff42f4505c2f6f4c4d573f9f8084163
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7598371
PMID 33161221
PQID 2458962906
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7598371
proquest_miscellaneous_2458962906
crossref_primary_10_1016_j_dsx_2020_10_022
pubmed_primary_33161221
elsevier_sciencedirect_doi_10_1016_j_dsx_2020_10_022
PublicationCentury 2000
PublicationDate 2020-11-01
PublicationDateYYYYMMDD 2020-11-01
PublicationDate_xml – month: 11
  year: 2020
  text: 2020-11-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Diabetes & metabolic syndrome clinical research & reviews
PublicationTitleAlternate Diabetes Metab Syndr
PublicationYear 2020
Publisher Elsevier Ltd
Diabetes India. Published by Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
– name: Diabetes India. Published by Elsevier Ltd
References Balnis, Adam, Chopra, Chieng, Feustel, Overmyer (bib14) 2020
No Title n.d. doi:10.1016/j.dsx.2020.08.003.
Lim, Pranata, Huang, Yonas, Soeroto, Supriyadi (bib49) 2020; 7
Hong Kong Baptist University. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range 2020.
Chroboczek, Lacoste, Wackenheim, Challan-Belval, Amar, Boisson (bib28) 2020
Gupta, Hussain, Misra (bib4) 2020
Burn, Tebe, Fernandez-Bertolin, Aragon, Recalde, Roel (bib26) 2020
Ji, Huh, Kang, Hong, Bae, Lee (bib16) 2020
Luo, Wan, Liu, Tong (bib11) 2018; 27
Marcos, Belhassen-Garcia, Sanchez- Puente, Sampedro-Gomez, Azibeiro, Dorado-Diaz (bib17) 2020
Giacomelli A, Ridolfo AL, Milazzo L, Oreni L, Bernacchia D, Siano M, et al. 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study. Pharmacol Res 2020:104931. doi:10.1016/j.phrs.2020.104931.
Mejia-Vilet, Cordova-Sanchez, Fernandez-Camargo, Mendez-Perez, Morales-Buenrostro, Hernandez-Gilsoul (bib18) 2020; 5
Giorgi Rossi, Ferroni, Spila Alegiani, Leoni, Pitter, Cereda (bib21) 2020
Pranata, Supriyadi, Huang, Permana, Lim, Yonas (bib50) 2020; 14
Charlson, Pompei, Ales, MacKenzie (bib6) 1987; 40
Price-Haywood, Price-Haywood, Burton, Fort, Seoane (bib20) 2020; 382
Gupta, Misra (bib5) 2020; 14
Christensen, Strange, Gislason, Torp-Pedersen, Gerds, Fosbøl (bib2) 2020
Pranata, Lim, Huang, Raharjo, Lukito (bib41) 2020; 21
Pranata, Soeroto, Ian, Lim, Santoso, Permana (bib37) 2020
Guan, Liang, Zhao, Liang, Chen, Li (bib3) 2020; 55
Lim, Pranata (bib39) 2020
Imam, Odish, Gill, O’Connor, Armstrong, Vanood (bib32) 2020
Lim, Pranata (bib44) 2020; 14
July, Pranata (bib51) 2020; 29
Pranata, Huang, Lim, Wahjoepramono, July (bib34) 2020
Pranata, Lim, Yonas, Vania, Lukito, Siswanto (bib38) 2020
Narain, Stefanov, Chau, Weber, Marder, Kaplan (bib19) 2020
World Health Organization (bib1) 2020
Regina, Papadimitriou-Olivgeris, Burger, Filippidis, Tschopp, Desgranges (bib15) 2020
Huang, Lim, Pranata (bib42) 2020; 14
Shashikumar, Wardi, Paul, Carlile, Brenner, Hibbert (bib23) 2020
Castro, Ross, McBride, Perlis (bib27) 2020
Sanchez-Montalva, Selares-Nadal, Espinosa-Pereiro, Fernandez-Hidalgo, Perez-Hoyos, Salvador (bib22) 2020
(bib13) 2020
Huang, Pranata (bib48) 2020; 8
Wan, Wang, Liu, Tong (bib10) 2014; 14
Guido, Guido, Claudio, Claudio, Massimo, Massimo (bib31) 2020; 76
Bhargava, Fukushima, Levine, Zhao, Tanveer, Szpunar (bib25) 2020; 19
Pranata, Lim, Yonas, Siswanto, Meyer (bib52) 2020; 15
Lim, Huang, Yonas, Vania, Pranata (bib36) 2020; 14
Pranata, Permana, Huang, Lim, Soetedjo, Supriyadi (bib43) 2020
Lim, Pranata (bib45) 2020
Quan, Li, Couris, Fushimi, Graham, Hider (bib8) 2011; 173
Vultaggio, Vivarelli, Virgili, Lucenteforte, Bartoloni, Nozzoli (bib24) 2020; S2213–2198
Garibaldi, Fiksel, Muschelli, Robinson, Rouhizadeh, Nagy (bib29) 2020; 5
Huang, Pranata, Lim, Oehadian, Alisjahbana (bib47) 2020; 14
Radovanovic, Seifert, Urban, Eberli, Rickli, Bertel (bib7) 2014; 100
Valeri, Robbins-Juarez, Stevens, Ahn, Rao, Radhakrishnan (bib46) 2020; 31
Austin, Wong, Uzzo, Beck, Egleston (bib33) 2015; 53
Yonas, Alwi, Pranata, Huang, Lim, Gutierrez (bib35) 2020
Stang (bib12) 2010; 25
Pranata (10.1016/j.dsx.2020.10.022_bib38) 2020
Giorgi Rossi (10.1016/j.dsx.2020.10.022_bib21) 2020
Pranata (10.1016/j.dsx.2020.10.022_bib52) 2020; 15
10.1016/j.dsx.2020.10.022_bib9
Guido (10.1016/j.dsx.2020.10.022_bib31) 2020; 76
Pranata (10.1016/j.dsx.2020.10.022_bib34) 2020
Shashikumar (10.1016/j.dsx.2020.10.022_bib23) 2020
Austin (10.1016/j.dsx.2020.10.022_bib33) 2015; 53
Marcos (10.1016/j.dsx.2020.10.022_bib17) 2020
10.1016/j.dsx.2020.10.022_bib30
Wan (10.1016/j.dsx.2020.10.022_bib10) 2014; 14
Yonas (10.1016/j.dsx.2020.10.022_bib35) 2020
Ji (10.1016/j.dsx.2020.10.022_bib16) 2020
Chroboczek (10.1016/j.dsx.2020.10.022_bib28) 2020
Narain (10.1016/j.dsx.2020.10.022_bib19) 2020
Lim (10.1016/j.dsx.2020.10.022_bib36) 2020; 14
Pranata (10.1016/j.dsx.2020.10.022_bib37) 2020
Lim (10.1016/j.dsx.2020.10.022_bib49) 2020; 7
Imam (10.1016/j.dsx.2020.10.022_bib32) 2020
Huang (10.1016/j.dsx.2020.10.022_bib42) 2020; 14
Price-Haywood (10.1016/j.dsx.2020.10.022_bib20) 2020; 382
Lim (10.1016/j.dsx.2020.10.022_bib45) 2020
Vultaggio (10.1016/j.dsx.2020.10.022_bib24) 2020; S2213–2198
Burn (10.1016/j.dsx.2020.10.022_bib26) 2020
Garibaldi (10.1016/j.dsx.2020.10.022_bib29) 2020; 5
Regina (10.1016/j.dsx.2020.10.022_bib15) 2020
Charlson (10.1016/j.dsx.2020.10.022_bib6) 1987; 40
Christensen (10.1016/j.dsx.2020.10.022_bib2) 2020
Radovanovic (10.1016/j.dsx.2020.10.022_bib7) 2014; 100
Castro (10.1016/j.dsx.2020.10.022_bib27) 2020
Bhargava (10.1016/j.dsx.2020.10.022_bib25) 2020; 19
Pranata (10.1016/j.dsx.2020.10.022_bib50) 2020; 14
Quan (10.1016/j.dsx.2020.10.022_bib8) 2011; 173
Luo (10.1016/j.dsx.2020.10.022_bib11) 2018; 27
Gupta (10.1016/j.dsx.2020.10.022_bib4) 2020
Stang (10.1016/j.dsx.2020.10.022_bib12) 2010; 25
Mejia-Vilet (10.1016/j.dsx.2020.10.022_bib18) 2020; 5
Huang (10.1016/j.dsx.2020.10.022_bib48) 2020; 8
World Health Organization (10.1016/j.dsx.2020.10.022_bib1) 2020
Sanchez-Montalva (10.1016/j.dsx.2020.10.022_bib22) 2020
Pranata (10.1016/j.dsx.2020.10.022_bib41) 2020; 21
Guan (10.1016/j.dsx.2020.10.022_bib3) 2020; 55
July (10.1016/j.dsx.2020.10.022_bib51) 2020; 29
Balnis (10.1016/j.dsx.2020.10.022_bib14) 2020
Valeri (10.1016/j.dsx.2020.10.022_bib46) 2020; 31
Huang (10.1016/j.dsx.2020.10.022_bib47) 2020; 14
Lim (10.1016/j.dsx.2020.10.022_bib39) 2020
Pranata (10.1016/j.dsx.2020.10.022_bib43) 2020
Lim (10.1016/j.dsx.2020.10.022_bib44) 2020; 14
10.1016/j.dsx.2020.10.022_bib40
Gupta (10.1016/j.dsx.2020.10.022_bib5) 2020; 14
References_xml – year: 2020
  ident: bib13
  article-title: Review Manager (RevMan)
– volume: 31
  start-page: 1409
  year: 2020
  ident: bib46
  article-title: Presentation and outcomes of patients with ESKD and COVID-19
  publication-title: J Am Soc Nephrol
  contributor:
    fullname: Radhakrishnan
– volume: 173
  start-page: 676
  year: 2011
  end-page: 682
  ident: bib8
  article-title: Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries
  publication-title: Am J Epidemiol
  contributor:
    fullname: Hider
– year: 2020
  ident: bib1
  article-title: Coronavirus disease (COVID-19) situation report – 131
  contributor:
    fullname: World Health Organization
– volume: 14
  year: 2020
  ident: bib47
  article-title: C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis
  publication-title: Ther Adv Respir Dis
  contributor:
    fullname: Alisjahbana
– volume: 29
  year: 2020
  ident: bib51
  article-title: Impact of the coronavirus disease pandemic on the number of strokes and mechanical thrombectomies: a systematic review and meta-analysis
  publication-title: J Stroke Cerebrovasc Dis
  contributor:
    fullname: Pranata
– volume: 15
  year: 2020
  ident: bib52
  article-title: Out-of-hospital cardiac arrest prognosis during the COVID-19 pandemic
  publication-title: Intern Emerg Med
  contributor:
    fullname: Meyer
– volume: S2213–2198
  start-page: 30611
  year: 2020
  end-page: 30615
  ident: bib24
  article-title: Prompt predicting of early clinical deterioration of moderate-to-severe COVID-19 patients: usefulness of a combined score using IL-6 in a preliminary study
  publication-title: J. Allergy Clin. Immunol. Pract.
  contributor:
    fullname: Nozzoli
– year: 2020
  ident: bib39
  article-title: Coronavirus disease 2019 (COVID-19) markedly increased mortality in patients with hip fracture – a systematic review and meta-analysis
  publication-title: J Clin Orthop Trauma
  contributor:
    fullname: Pranata
– year: 2020
  ident: bib32
  article-title: Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States
  publication-title: J Intern Med
  contributor:
    fullname: Vanood
– year: 2020
  ident: bib28
  article-title: Beneficial effect of corticosteroids in severe COVID-19 pneumonia: a propensity score matching analysis
  publication-title: MedRxiv
  contributor:
    fullname: Boisson
– year: 2020
  ident: bib15
  article-title: Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study
  publication-title: MedRxiv
  contributor:
    fullname: Desgranges
– year: 2020
  ident: bib19
  article-title: Comparative survival analysis of immunomodulatory therapy for COVID-19 ’cytokine storm’: a retrospective observational cohort study
  publication-title: MedRxiv
  contributor:
    fullname: Kaplan
– volume: 55
  start-page: 2000547
  year: 2020
  ident: bib3
  article-title: Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
  publication-title: Eur Respir J
  contributor:
    fullname: Li
– volume: 14
  start-page: 135
  year: 2014
  ident: bib10
  article-title: Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
  publication-title: BMC Med Res Methodol
  contributor:
    fullname: Tong
– volume: 19
  start-page: 1
  year: 2020
  end-page: 7
  ident: bib25
  article-title: Predictors for severe COVID-19 infection
  publication-title: Clin Infect Dis
  contributor:
    fullname: Szpunar
– volume: 8
  year: 2020
  ident: bib48
  article-title: Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
  publication-title: J Intensive Care
  contributor:
    fullname: Pranata
– year: 2020
  ident: bib2
  article-title: Charlson comorbidity index score and risk of severe outcome and death in Danish COVID-19 patients
  publication-title: J Gen Intern Med
  contributor:
    fullname: Fosbøl
– volume: 25
  start-page: 603
  year: 2010
  end-page: 605
  ident: bib12
  article-title: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
  publication-title: Eur J Epidemiol
  contributor:
    fullname: Stang
– volume: 100
  start-page: 288
  year: 2014
  ident: bib7
  article-title: Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012
  publication-title: Heart
  contributor:
    fullname: Bertel
– volume: 5
  start-page: 20111864
  year: 2020
  ident: bib29
  article-title: Patient trajectories and risk factors for severe outcomes among persons hospitalized for COVID-19 in the Maryland/DC region
  publication-title: MedRxiv
  contributor:
    fullname: Nagy
– year: 2020
  ident: bib21
  article-title: Survival of hospitalized COVID-19 patients in Northern Italy: a population-based cohort study by the ITA-COVID19 Network
  publication-title: MedRxiv
  contributor:
    fullname: Cereda
– start-page: 104949
  year: 2020
  ident: bib34
  article-title: Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 – systematic review, meta-analysis, and meta-regression
  publication-title: J Stroke Cerebrovasc Dis
  contributor:
    fullname: July
– year: 2020
  ident: bib37
  article-title: Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19
  publication-title: Int J Tubercul Lung Dis
  contributor:
    fullname: Permana
– volume: 14
  start-page: 251
  year: 2020
  end-page: 254
  ident: bib5
  article-title: Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
  publication-title: Diabetes Metab Syndr Clin Res Rev
  contributor:
    fullname: Misra
– volume: 14
  start-page: 979
  year: 2020
  end-page: 980
  ident: bib36
  article-title: A wave of non-communicable diseases following the COVID-19 pandemic
  publication-title: Diabetes Metab Syndr Clin Res Rev
  contributor:
    fullname: Pranata
– volume: 27
  start-page: 1785
  year: 2018
  end-page: 1805
  ident: bib11
  article-title: Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
  publication-title: Stat Methods Med Res
  contributor:
    fullname: Tong
– volume: 21
  year: 2020
  ident: bib41
  article-title: Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression
  publication-title: J Renin-Angiotensin-Aldosterone Syst JRAAS
  contributor:
    fullname: Lukito
– year: 2020
  ident: bib23
  article-title: Development and prospective validation of a transparent deep learning algorithm for predicting need for mechanical ventilation
  publication-title: MedRxiv. Prepr Serv. Heal Sci.
  contributor:
    fullname: Hibbert
– year: 2020
  ident: bib22
  article-title: Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study
  publication-title: MedRxiv
  contributor:
    fullname: Salvador
– volume: 14
  start-page: 395
  year: 2020
  end-page: 403
  ident: bib42
  article-title: Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression
  publication-title: Diabetes Metab Syndr Clin Res Rev
  contributor:
    fullname: Pranata
– volume: 382
  start-page: 2534
  year: 2020
  end-page: 2543
  ident: bib20
  article-title: Hospitalization and mortality among black patients and white patients with Covid-19
  publication-title: N Engl J Med
  contributor:
    fullname: Seoane
– year: 2020
  ident: bib4
  article-title: Diabetes and COVID-19: evidence, current status and unanswered research questions
  publication-title: Eur J Clin Nutr
  contributor:
    fullname: Misra
– volume: 7
  year: 2020
  ident: bib49
  article-title: Multiorgan failure with emphasis on acute kidney injury and severity of COVID-19: systematic review and meta-analysis
  publication-title: Can J Kidney Heal Dis
  contributor:
    fullname: Supriyadi
– year: 2020
  ident: bib45
  article-title: The insidious threat of jamu and unregulated traditional medicines in the COVID-19 era
  publication-title: Diabetes Metab Syndr Clin Res Rev
  contributor:
    fullname: Pranata
– year: 2020
  ident: bib38
  article-title: Body mass index and outcome in patients with COVID-19: a dose-response meta-analysis
  publication-title: Diabetes Metab
  contributor:
    fullname: Siswanto
– year: 2020
  ident: bib17
  article-title: Development of a severity of disease score and classification model by machine learning for hospitalized COVID-19 patients
  publication-title: MedRxiv
  contributor:
    fullname: Dorado-Diaz
– year: 2020
  ident: bib43
  article-title: The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis
  publication-title: Diabetes Metab Syndr Clin Res Rev
  contributor:
    fullname: Supriyadi
– volume: 5
  year: 2020
  ident: bib18
  article-title: A risk score to predict admission to intensive care unit in patients with COVID-19: the ABC-GOALS score
  publication-title: MedRxiv
  contributor:
    fullname: Hernandez-Gilsoul
– year: 2020
  ident: bib16
  article-title: Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea
  publication-title: MedRxiv
  contributor:
    fullname: Lee
– volume: 76
  start-page: 366
  year: 2020
  end-page: 372
  ident: bib31
  article-title: Age and multimorbidity predict death among COVID-19 patients
  publication-title: Hypertension
  contributor:
    fullname: Massimo
– year: 2020
  ident: bib27
  article-title: Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records
  publication-title: MedRxiv
  contributor:
    fullname: Perlis
– volume: 53
  year: 2015
  ident: bib33
  article-title: Why summary comorbidity measures such as the Charlson comorbidity index and elixhauser score work
  publication-title: Med Care
  contributor:
    fullname: Egleston
– year: 2020
  ident: bib35
  article-title: Effect of heart failure on the outcome of COVID-19 - a meta analysis and systematic review
  publication-title: Am J Emerg Med
  contributor:
    fullname: Gutierrez
– volume: 14
  year: 2020
  ident: bib50
  article-title: The association between chronic kidney disease and new onset renal replacement therapy on the outcome of COVID-19 patients: a meta-analysis
  publication-title: Clin Med Insights Circulatory, Respir Pulm Med
  contributor:
    fullname: Yonas
– year: 2020
  ident: bib26
  article-title: The natural history of symptomatic COVID-19 in Catalonia, Spain: a multi-state model including 109,367 outpatient diagnoses, 18,019 hospitalisations, and 5,585 COVID-19 deaths among 5,627,520 people
  publication-title: MedRxiv
  contributor:
    fullname: Roel
– volume: 40
  start-page: 373
  year: 1987
  end-page: 383
  ident: bib6
  article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
  publication-title: J Chron Dis
  contributor:
    fullname: MacKenzie
– year: 2020
  ident: bib14
  article-title: Higher plasma levels of Chemokine CCL19 are associated with poor SARS-CoV-2 acute respiratory distress syndrome (ARDS) outcomes
  publication-title: MedRxiv
  contributor:
    fullname: Overmyer
– volume: 14
  year: 2020
  ident: bib44
  article-title: Worrying situation regarding the use of dexamethasone for COVID-19
  publication-title: Ther Adv Respir Dis
  contributor:
    fullname: Pranata
– volume: 14
  start-page: 135
  year: 2014
  ident: 10.1016/j.dsx.2020.10.022_bib10
  article-title: Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
  publication-title: BMC Med Res Methodol
  doi: 10.1186/1471-2288-14-135
  contributor:
    fullname: Wan
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib45
  article-title: The insidious threat of jamu and unregulated traditional medicines in the COVID-19 era
  publication-title: Diabetes Metab Syndr Clin Res Rev
  doi: 10.1016/j.dsx.2020.06.022
  contributor:
    fullname: Lim
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib15
  article-title: Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study
  publication-title: MedRxiv
  contributor:
    fullname: Regina
– volume: 29
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib51
  article-title: Impact of the coronavirus disease pandemic on the number of strokes and mechanical thrombectomies: a systematic review and meta-analysis
  publication-title: J Stroke Cerebrovasc Dis
  doi: 10.1016/j.jstrokecerebrovasdis.2020.105185
  contributor:
    fullname: July
– volume: 14
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib47
  article-title: C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis
  publication-title: Ther Adv Respir Dis
  doi: 10.1177/1753466620937175
  contributor:
    fullname: Huang
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib27
  article-title: Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records
  publication-title: MedRxiv
  contributor:
    fullname: Castro
– ident: 10.1016/j.dsx.2020.10.022_bib40
  doi: 10.1016/j.dsx.2020.08.003
– volume: 14
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib50
  article-title: The association between chronic kidney disease and new onset renal replacement therapy on the outcome of COVID-19 patients: a meta-analysis
  publication-title: Clin Med Insights Circulatory, Respir Pulm Med
  doi: 10.1177/1179548420959165
  contributor:
    fullname: Pranata
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib26
  article-title: The natural history of symptomatic COVID-19 in Catalonia, Spain: a multi-state model including 109,367 outpatient diagnoses, 18,019 hospitalisations, and 5,585 COVID-19 deaths among 5,627,520 people
  publication-title: MedRxiv
  contributor:
    fullname: Burn
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib28
  article-title: Beneficial effect of corticosteroids in severe COVID-19 pneumonia: a propensity score matching analysis
  publication-title: MedRxiv
  contributor:
    fullname: Chroboczek
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib23
  article-title: Development and prospective validation of a transparent deep learning algorithm for predicting need for mechanical ventilation
  publication-title: MedRxiv. Prepr Serv. Heal Sci.
  contributor:
    fullname: Shashikumar
– volume: 76
  start-page: 366
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib31
  article-title: Age and multimorbidity predict death among COVID-19 patients
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.120.15324
  contributor:
    fullname: Guido
– volume: 14
  start-page: 979
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib36
  article-title: A wave of non-communicable diseases following the COVID-19 pandemic
  publication-title: Diabetes Metab Syndr Clin Res Rev
  doi: 10.1016/j.dsx.2020.06.050
  contributor:
    fullname: Lim
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib37
  article-title: Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19
  publication-title: Int J Tubercul Lung Dis
  doi: 10.5588/ijtld.20.0278
  contributor:
    fullname: Pranata
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib19
  article-title: Comparative survival analysis of immunomodulatory therapy for COVID-19 ’cytokine storm’: a retrospective observational cohort study
  publication-title: MedRxiv
  contributor:
    fullname: Narain
– volume: 382
  start-page: 2534
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib20
  article-title: Hospitalization and mortality among black patients and white patients with Covid-19
  publication-title: N Engl J Med
  doi: 10.1056/NEJMsa2011686
  contributor:
    fullname: Price-Haywood
– volume: 55
  start-page: 2000547
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib3
  article-title: Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
  publication-title: Eur Respir J
  doi: 10.1183/13993003.00547-2020
  contributor:
    fullname: Guan
– volume: S2213–2198
  start-page: 30611
  issue: 20
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib24
  article-title: Prompt predicting of early clinical deterioration of moderate-to-severe COVID-19 patients: usefulness of a combined score using IL-6 in a preliminary study
  publication-title: J. Allergy Clin. Immunol. Pract.
  contributor:
    fullname: Vultaggio
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib43
  article-title: The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis
  publication-title: Diabetes Metab Syndr Clin Res Rev
  doi: 10.1016/j.dsx.2020.06.047
  contributor:
    fullname: Pranata
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib1
  contributor:
    fullname: World Health Organization
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib17
  article-title: Development of a severity of disease score and classification model by machine learning for hospitalized COVID-19 patients
  publication-title: MedRxiv
  contributor:
    fullname: Marcos
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib22
  article-title: Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study
  publication-title: MedRxiv
  contributor:
    fullname: Sanchez-Montalva
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib39
  article-title: Coronavirus disease 2019 (COVID-19) markedly increased mortality in patients with hip fracture – a systematic review and meta-analysis
  publication-title: J Clin Orthop Trauma
  contributor:
    fullname: Lim
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib14
  article-title: Higher plasma levels of Chemokine CCL19 are associated with poor SARS-CoV-2 acute respiratory distress syndrome (ARDS) outcomes
  publication-title: MedRxiv
  contributor:
    fullname: Balnis
– start-page: 104949
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib34
  article-title: Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 – systematic review, meta-analysis, and meta-regression
  publication-title: J Stroke Cerebrovasc Dis
  doi: 10.1016/j.jstrokecerebrovasdis.2020.104949
  contributor:
    fullname: Pranata
– volume: 7
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib49
  article-title: Multiorgan failure with emphasis on acute kidney injury and severity of COVID-19: systematic review and meta-analysis
  publication-title: Can J Kidney Heal Dis
  contributor:
    fullname: Lim
– volume: 19
  start-page: 1
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib25
  article-title: Predictors for severe COVID-19 infection
  publication-title: Clin Infect Dis
  contributor:
    fullname: Bhargava
– volume: 15
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib52
  article-title: Out-of-hospital cardiac arrest prognosis during the COVID-19 pandemic
  publication-title: Intern Emerg Med
  doi: 10.1007/s11739-020-02428-7
  contributor:
    fullname: Pranata
– volume: 173
  start-page: 676
  year: 2011
  ident: 10.1016/j.dsx.2020.10.022_bib8
  article-title: Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwq433
  contributor:
    fullname: Quan
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib32
  article-title: Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States
  publication-title: J Intern Med
  doi: 10.1111/joim.13119
  contributor:
    fullname: Imam
– volume: 25
  start-page: 603
  year: 2010
  ident: 10.1016/j.dsx.2020.10.022_bib12
  article-title: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
  publication-title: Eur J Epidemiol
  doi: 10.1007/s10654-010-9491-z
  contributor:
    fullname: Stang
– volume: 14
  start-page: 251
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib5
  article-title: Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
  publication-title: Diabetes Metab Syndr Clin Res Rev
  doi: 10.1016/j.dsx.2020.03.012
  contributor:
    fullname: Gupta
– volume: 8
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib48
  article-title: Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
  publication-title: J Intensive Care
  contributor:
    fullname: Huang
– volume: 100
  start-page: 288
  year: 2014
  ident: 10.1016/j.dsx.2020.10.022_bib7
  article-title: Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012
  publication-title: Heart
  doi: 10.1136/heartjnl-2013-304588
  contributor:
    fullname: Radovanovic
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib4
  article-title: Diabetes and COVID-19: evidence, current status and unanswered research questions
  publication-title: Eur J Clin Nutr
  doi: 10.1038/s41430-020-0652-1
  contributor:
    fullname: Gupta
– volume: 5
  start-page: 20111864
  issue: 24
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib29
  article-title: Patient trajectories and risk factors for severe outcomes among persons hospitalized for COVID-19 in the Maryland/DC region
  publication-title: MedRxiv
  contributor:
    fullname: Garibaldi
– volume: 31
  start-page: 1409
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib46
  article-title: Presentation and outcomes of patients with ESKD and COVID-19
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2020040470
  contributor:
    fullname: Valeri
– volume: 53
  year: 2015
  ident: 10.1016/j.dsx.2020.10.022_bib33
  article-title: Why summary comorbidity measures such as the Charlson comorbidity index and elixhauser score work
  publication-title: Med Care
  doi: 10.1097/MLR.0b013e318297429c
  contributor:
    fullname: Austin
– volume: 14
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib44
  article-title: Worrying situation regarding the use of dexamethasone for COVID-19
  publication-title: Ther Adv Respir Dis
  doi: 10.1177/1753466620942131
  contributor:
    fullname: Lim
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib35
  article-title: Effect of heart failure on the outcome of COVID-19 - a meta analysis and systematic review
  publication-title: Am J Emerg Med
  doi: 10.1016/j.ajem.2020.07.009
  contributor:
    fullname: Yonas
– volume: 5
  issue: 12
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib18
  article-title: A risk score to predict admission to intensive care unit in patients with COVID-19: the ABC-GOALS score
  publication-title: MedRxiv
  contributor:
    fullname: Mejia-Vilet
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib38
  article-title: Body mass index and outcome in patients with COVID-19: a dose-response meta-analysis
  publication-title: Diabetes Metab
  doi: 10.1016/j.diabet.2020.07.005
  contributor:
    fullname: Pranata
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib21
  article-title: Survival of hospitalized COVID-19 patients in Northern Italy: a population-based cohort study by the ITA-COVID19 Network
  publication-title: MedRxiv
  contributor:
    fullname: Giorgi Rossi
– volume: 21
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib41
  article-title: Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression
  publication-title: J Renin-Angiotensin-Aldosterone Syst JRAAS
  contributor:
    fullname: Pranata
– ident: 10.1016/j.dsx.2020.10.022_bib30
  doi: 10.1016/j.phrs.2020.104931
– volume: 14
  start-page: 395
  year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib42
  article-title: Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression
  publication-title: Diabetes Metab Syndr Clin Res Rev
  doi: 10.1016/j.dsx.2020.04.018
  contributor:
    fullname: Huang
– ident: 10.1016/j.dsx.2020.10.022_bib9
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib16
  article-title: Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea
  publication-title: MedRxiv
  contributor:
    fullname: Ji
– year: 2020
  ident: 10.1016/j.dsx.2020.10.022_bib2
  article-title: Charlson comorbidity index score and risk of severe outcome and death in Danish COVID-19 patients
  publication-title: J Gen Intern Med
  doi: 10.1007/s11606-020-05991-z
  contributor:
    fullname: Christensen
– volume: 40
  start-page: 373
  year: 1987
  ident: 10.1016/j.dsx.2020.10.022_bib6
  article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
  publication-title: J Chron Dis
  doi: 10.1016/0021-9681(87)90171-8
  contributor:
    fullname: Charlson
– volume: 27
  start-page: 1785
  year: 2018
  ident: 10.1016/j.dsx.2020.10.022_bib11
  article-title: Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
  publication-title: Stat Methods Med Res
  doi: 10.1177/0962280216669183
  contributor:
    fullname: Luo
SSID ssj0055929
Score 2.607977
SecondaryResourceType review_article
Snippet The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. Therefore, thorough comorbidities assessment can help establish risk...
• The ongoing COVID-19 pandemic is disproportionately affecting patients with comorbidities. • Charlson Comorbidity Index (CCI) has been widely used as a...
SourceID pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 2103
SubjectTerms Charlson comorbidity index
Comorbidity - trends
COVID-19
COVID-19 - diagnosis
COVID-19 - mortality
COVID-19 - therapy
Hospitalization - trends
Humans
Mechanical ventilation
Mortality
Prospective Studies
Retrospective Studies
Risk Assessment - trends
Severity
Title Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis
URI https://dx.doi.org/10.1016/j.dsx.2020.10.022
https://www.ncbi.nlm.nih.gov/pubmed/33161221
https://www.proquest.com/docview/2458962906
https://pubmed.ncbi.nlm.nih.gov/PMC7598371
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Li9swEBbZLJReSt-bvlChpwYHW5Yju7ewSdnd0gfdpezNyLZEslB7iWPa_vvOSJadpA_aQi8mVhRF8XwZzYxmPhHyIhageEWkvCDnCToogZdkAfOkyotIMeHHEmuHT87Fu8t4vuCLwcCd7tm3_VdJQxvIGitn_0La3aDQAK9B5nAFqcP1j-Ru9s_xWEEYvFpnqwLNbMOJaHlZTRI5ZmqZYMF1Va3HVbOBRpOZNT5-_-l07gWJI1ytben6PuGzzSP-rDbSky2tybaZO-8julPTK0P64Y4eoa_HbLmGlqZjy4zap3zAzN80Neb1Lu3RU-OPk9mkD9-W65UtaTur6mXTLTAfYP2VrVUsv8GTL_pgB1IlrJoaC7v2qwba2Ac4usFO7KMryukzoFCHgw9oUGeXONeGlYRt3NQpfr4F8F0t7odbFgHcJj9dbWzg42pS1F8nOL0J5gnaMus9Eu9znBTOieFWdOD7B-SQgWrkQ3I4O11cnjnrARw8c7Je9yPcTrzJSdz7ol_ZUj_6Svspv1s21MVtcqt1fujMovYOGajyLrnxtk3vuEe-OPDSLfBSA14KeKOSduCllaYIXurAC92oAy914H1FZ7SHLrUAM0PtQPc-uXi9uDg-8dqTQbw8CsTGi3I_UdMMzGXf1yzLtSg0LNRwlysZ-CLRmjPNwbrPmZ5qnvMiEqFOdOzjNnv4gAzLqlRHhBYqRM7JMAejjespT7I8YjKIJVdZwiM1Ii_dI06vLf9L6hIjr1KQR4rywCaQx4hwJ4S0NWCtYZoCYn73sedOYCkod9yxk6WqmjplPIqTKZ7IMCIPrQC7WYQhOGuMBSMidkTbdUDi-N13ytXSEMiLKIlDETz6t-k-Jjf7_-ITMtysG_WUHNRF86wF83cpg-jH
link.rule.ids 230,315,782,786,887,27934,27935
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Charlson+comorbidity+index+and+a+composite+of+poor+outcomes+in+COVID-19+patients%3A+A+systematic+review+and+meta-analysis&rft.jtitle=Diabetes+%26+metabolic+syndrome+clinical+research+%26+reviews&rft.au=Tuty+Kuswardhani%2C+R.A.&rft.au=Henrina%2C+Joshua&rft.au=Pranata%2C+Raymond&rft.au=Anthonius+Lim%2C+Michael&rft.date=2020-11-01&rft.pub=Elsevier+Ltd&rft.issn=1871-4021&rft.eissn=1878-0334&rft.volume=14&rft.issue=6&rft.spage=2103&rft.epage=2109&rft_id=info:doi/10.1016%2Fj.dsx.2020.10.022&rft.externalDocID=S1871402120304100
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1871-4021&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1871-4021&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1871-4021&client=summon